Leading researchers team up to bring promising chemotherapy treatment to human trials

In 2015, University of Alberta cancer researcher Jack Tuszynski learned that his patent application for a promising chemotherapy treatment for people suffering from metastatic bladder cancer had been rejected by the U.S. Patent Office.

source https://medicalxpress.com/news/2021-11-team-chemotherapy-treatment-human-trials.html